IXC 0.00% 6.6¢ invex therapeutics ltd

As we start to think about a second indication and the...

  1. 941 Posts.
    lightbulb Created with Sketch. 302
    As we start to think about a second indication and the possibility of that indication being TBI and the further possibility that there might be some grant funding from the Ministry of Defence in the UK, I think the following might be of interest.

    Alex Sinclair and James L Mitchell have co-authored numerous academic papers over the last few years. Of particular interest to us they are both co-authors on the published results from our Phase I & Phase II results.

    So who is James L Mitchell I hear you ask, well if we look at his declared affiliations on the published Phase II paper we can get a sense of who he is.

    2410007 (medrxiv.org) this is the link to the paper.

    Here are his declared affiliations

    1 University of Birmingham, Institute of Metabolism and Systems Research; Birmingham,
    United Kingdom.
    2 University Hospitals Birmingham NHS Foundation Trust, Department of Neurology;
    Birmingham, United Kingdom.
    3 Academic Department of Military Rehabilitation, Defence Medical Rehabilitation Centre;
    Stanford Hall, United Kingdom.

    This is the disclosure on funding.

    JLM was funded by the Ministry of Defence for the duration of the study.

    On twitter he is known as @ArmyBrianDoc,

    It appears to me that the UK MOD has more than a passing interest in Presendin and I suspect that interest does not stem from the high prevalence of IIH in military ranks.

 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.6¢
Change
0.000(0.00%)
Mkt cap ! $4.960M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 100000 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.8¢ 10000 1
View Market Depth
Last trade - 16.12pm 12/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.